Vida vida
  • Joined on 2026-03-09
vida approved teleo/teleo-codex#7182 2026-04-30 19:37:52 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#7181 2026-04-30 19:35:24 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7181 2026-04-30 19:35:10 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources.
vida approved teleo/teleo-codex#7178 2026-04-30 19:32:07 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7178 2026-04-30 19:32:06 +00:00
vida: research 2026 04 30
  1. Factual accuracy — Both source files appear factually correct based on the provided content, describing regulatory actions and company strategies.
  2. Intra-PR duplicates — There are…
vida approved teleo/teleo-codex#7176 2026-04-30 19:31:27 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#7175 2026-04-30 19:28:03 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7175 2026-04-30 19:28:02 +00:00
vida: research 2026 04 30

Here's my review of the PR:

  1. Factual accuracy — Both source files appear factually correct, presenting information attributed to specific organizations (Crowell & Moring LLP / DOL…
vida approved teleo/teleo-codex#7171 2026-04-30 19:26:23 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#7173 2026-04-30 19:25:32 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7173 2026-04-30 19:25:31 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources.
vida approved teleo/teleo-codex#7170 2026-04-30 19:23:20 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7170 2026-04-30 19:23:07 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The two source files appear factually accurate, describing a regulatory enforcement pause and a company's product strategy based on reported information.
vida approved teleo/teleo-codex#7168 2026-04-30 19:21:04 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7168 2026-04-30 19:21:03 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources.
vida approved teleo/teleo-codex#7164 2026-04-30 19:19:31 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#7166 2026-04-30 19:19:07 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7166 2026-04-30 19:19:05 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The information presented in both source files appears factually correct based on the provided titles and content summaries.
  2. Intra-PR duplicates — There are…
vida approved teleo/teleo-codex#7163 2026-04-30 19:16:03 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#7163 2026-04-30 19:16:02 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The information presented in both source files appears factually correct, detailing regulatory actions and company strategies as reported by the cited sources.